Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laird Cameron
Observed names:
Laird B Cameron,
Laird B. Cameron
Institutions:
University of Auckland,
Auckland City Hospital,
Health New Zealand
Observed institutions:
University of Auckland,
Peter MacCallum Cancer Centre,
Auckland City Hospital,
Auckland District Health Board,
Capital and Coast District Health Board,
Medical Research Institute of New Zealand,
Health New Zealand
show all 7
ORCID:
0009-0009-8731-5307
Observed ORCID:
0009-0009-8731-5307
OpenAlex ID:
A5072564095
Works
23
Awards
1
The risk of serious adverse outcomes associated with hypoxaemia and hyperoxaemia in acute exacerbations of COPD
2012
·
Laird Cameron
, Janine Pilcher
, et al.
·
Postgraduate Medical Journal
·
82
BRAF Inhibition inBRAFV600E-Positive Anaplastic Thyroid Carcinoma
2016
·
Annette M. Lim
, Graham R. Taylor
, et al.
·
Journal of the National Comprehensive Cancer Network
·
46
PDF
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
2019
·
Laird B Cameron
, Nadia Hitchen
, et al.
·
Cochrane Database of Systematic Reviews
·
33
New Treatment Options for ALK-Rearranged Non-Small Cell Lung Cancer
2015
·
Laird Cameron
, Benjamin Solomon
·
Current Treatment Options in Oncology
·
32
Venous thromboembolism risk associated with protracted work- and computer-related seated immobility: A case-control study
2016
·
Irene Braithwaite
, Bridget Healy
, et al.
·
JRSM Open
·
31
Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution
2017
·
Laird B Cameron
, Damian H S Jiang
, et al.
·
Cancer Imaging
·
30
PDF
Delivery of titrated oxygen via a self-inflating resuscitation bag
2012
·
Paul Young
, Janine Pilcher
, et al.
·
Resuscitation
·
23
Lower limb immobilisation and venous thromboembolism risk: combined case–control studies
2016
·
Irene Braithwaite
, Bridget Healy
, et al.
·
Postgraduate Medical Journal
·
22
Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non‐small‐cell lung cancer in New Zealand
2019
·
Mark J. McKeage
, Sandar Tin Tin
, et al.
·
Internal Medicine Journal
·
19
Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: Recent Progress and Future Directions
2015
·
Laird Cameron
, Benjamin Solomon
·
Drugs
·
19
Comparative audit of oxygen use in the prehospital setting in acute COPD exacerbation over 5 years
2013
·
Janine Pilcher
, Laird Cameron
, et al.
·
Emergency Medicine Journal
·
18
Access to and Timeliness of Lung Cancer Surgery, Radiation Therapy, and Systemic Therapy in New Zealand: A Universal Health Care Context
2024
·
Jason Gurney
, Anna Davies
, et al.
·
JCO Global Oncology
·
16
Osimertinib in NSCLC: Real-World Data From New Zealand
2020
·
Yeojeong Jane So
, Anne Fraser
, et al.
·
JTO Clinical and Research Reports
·
8
PDF
Abstract CT005: Phase I study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors
2016
·
Jayesh Desai
, Hui Gan
, et al.
·
Cancer Research
·
6
National variation in the treatment of lung cancer in a universal healthcare context
2025
·
Jason Gurney
, Anna Davies
, et al.
·
British Journal of Cancer
·
5
PDF
A Randomized Phase 2 Trial of Nivolumab and Stereotactic Ablative Body Radiation Therapy in Advanced Non-Small Cell Lung Cancer, Progressing After First- or Second-Line Chemotherapy (NIVORAD)
2025
·
Gargi Kothari
, Kenneth J. O’Byrne
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
4
Improving lung cancer survival outcomes for Māori
2025
·
Jason Gurney
, James Stanley
, et al.
·
New Zealand Medical Journal
·
4
PDF
Closing the equity gap in access to early lung cancer diagnosis in Aotearoa: key informant perspectives and recommendations for action
2025
·
Virginia Signal
, Moira Smith
, et al.
·
Journal of Primary Health Care
·
3
PDF
Equity of access to pathological diagnosis and bronchoscopy for lung cancer in Aotearoa New Zealand
2024
·
Jason Gurney
, Anna Davies
, et al.
·
New Zealand Medical Journal
·
3
PDF
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study
2025
·
Phyu Sin Aye
, Joanne Barnes
, et al.
·
JMIR Cancer
·
2
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation–Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy
2024
·
Phyu Sin Aye
, Joanne Barnes
, et al.
·
JMIR Research Protocols
·
1
Mind the Graph: Foregone Health Gains in Lung Cancer
2017
·
Laird Cameron
, Richard Sullivan
, et al.
·
Seminars in Oncology
·
1
Use of Novel National Data Sets to Monitor Chemotherapy Use and Outcomes: A Retrospective Cohort Study of Non–Small-Cell Lung Cancer in Aotearoa New Zealand
2024
·
Alice M. Minhinnick
, Alexander H. Dunn
, et al.
·
JCO Oncology Practice
Show more works
View as search
Works count:
23
Citation count:
408
H-index:
12
I10-index:
12
Year
Topic
Type